Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke

PHASE2RecruitingINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

December 15, 2025

Study Completion Date

March 15, 2026

Conditions
StrokeInflammation
Interventions
DRUG

Fingolimod

Patients randomized to fingolimod will also receive fingolimod (Gilenya, Novartis) at a dosage of 0.5 mg once daily, for three consecutive days, with the first dose being given at the time in which patients are enrolled which is about one hour prior to mechanical thrombectomy.

OTHER

Placebo

Patients randomized to fingolimod will also receive placebo once daily, for three consecutive days, with the first dose being given at the time in which patients are enrolled which is about one hour prior to mechanical thrombectomy.

Trial Locations (1)

310009

RECRUITING

The second affiliated hospital of Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

Shaoxing People's Hospital

OTHER

collaborator

Affiliated Hospital of Jiaxing University

OTHER

collaborator

Huizhou Municipal Central Hospital

OTHER

collaborator

The Second Affiliated Hospital of Jiaxing University

OTHER

collaborator

Jinhua Center Hospital

UNKNOWN

collaborator

Taizhou Hospital

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER